EUSA 📈 iShares MSCI USA Equal - Overview

Exchange: NYSE ARCA • Country: USA • Currency: USD • Type: Etf • ISIN: US4642866812 • Mid-Cap Blend

EUSA: Stocks, US, Equities, Large, Mid, Capitalization

The iShares MSCI USA Equal Weighted ETF, listed on NYSE ARCA under the ticker EUSA, is designed to track the performance of an equally-weighted index that comprises large- and mid-capitalization U.S. equity securities. This means that the fund allocates its investments equally across the various component securities of its underlying index, rather than weighting them by market capitalization. By doing so, the fund provides a unique alternative to traditional market capitalization-weighted indices, such as its parent index, the MSCI USA Index. This approach can potentially reduce concentration risk and provide more balanced exposure to the U.S. equity market.

The fund's investment strategy involves investing at least 80% of its assets in the component securities of its underlying index, as well as in investments that have similar economic characteristics to these securities. This allows the fund to maintain a high level of consistency with its underlying index, while also providing some flexibility to manage its portfolio efficiently. The fund is listed in the United States and has an ISIN of US4642866812, making it accessible to a wide range of investors. As an exchange-traded fund (ETF), it offers the benefits of transparency, liquidity, and diversification, making it a popular choice for investors seeking to gain exposure to the U.S. equity market.

In terms of its category, the iShares MSCI USA Equal Weighted ETF is classified as a Mid-Cap Blend ETF, indicating that it focuses on mid-capitalization stocks and employs a blend of growth and value investment styles. This means that the fund's portfolio is likely to include a mix of established companies with stable earnings and growth potential, as well as smaller companies with higher growth prospects. By investing in this fund, investors can gain access to a diversified portfolio of U.S. mid-capitalization stocks, which can provide a unique combination of growth and income potential. For more information, investors can visit the fund's website at http://www.ishares.com.

Additional Sources for EUSA ETF

EUSA ETF Overview

Market Cap in USD 1,132m
Category Mid-Cap Blend
TER 0.09%
IPO / Inception 2010-05-05

EUSA ETF Ratings

Growth 5y 63.5%
Fundamental -
Dividend 54.2%
Rel. Strength Industry -23.4
Analysts -
Fair Price Momentum 97.32 USD
Fair Price DCF -

EUSA Dividends

Dividend Yield 12m 1.44%
Yield on Cost 5y 2.33%
Annual Growth 5y 6.09%
Payout Consistency 96.7%

EUSA Growth Ratios

Growth Correlation 3m -0.4%
Growth Correlation 12m 90.6%
Growth Correlation 5y 72.4%
CAGR 5y 10.28%
CAGR/Mean DD 5y 1.28
Sharpe Ratio 12m 1.20
Alpha -7.14
Beta 1.07
Volatility 15.26%
Current Volume 38.7k
Average Volume 20d 87.9k
What is the price of EUSA stocks?
As of January 18, 2025, the stock is trading at USD 98.36 with a total of 38,700 shares traded.
Over the past week, the price has changed by +3.96%, over one month by +0.17%, over three months by +1.60% and over the past year by +21.56%.
Is iShares MSCI USA Equal a good stock to buy?
Yes. Based on ValueRay Analyses, iShares MSCI USA Equal (NYSE ARCA:EUSA) is currently (January 2025) a good stock to buy. It has a ValueRay Growth Rating of 63.54 and therefor a clear technical positive rating according to historical growth.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of EUSA as of January 2025 is 97.32. This means that EUSA is currently overvalued and has a potential downside of -1.06%.
Is EUSA a buy, sell or hold?
iShares MSCI USA Equal has no consensus analysts rating.
What are the forecast for EUSA stock price target?
According to ValueRays Forecast Model, EUSA iShares MSCI USA Equal will be worth about 108.5 in January 2026. The stock is currently trading at 98.36. This means that the stock has a potential upside of +10.29%.
Issuer Forecast Upside
Wallstreet Target Price - -
Analysts Target Price - -
ValueRay Target Price 108.5 10.3%